21 CFR 522.275

§ 522.275 N-Butylscopolammonium.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.275, § 522.275 N-Butylscopolammonium, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87400
Permanent ID: ys:prov:87400@1
SHA-256: 90d25aedae51eb238c64db6d804df6281b44044382780f0969715c95eec9dd3b

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains 20 milligrams (mg) N-butylscopolammonium bromide. (b) Sponsor. See No. 000010 in § 510.600(c) of this chapter. (c) Conditions of use in horses—(1) Amount. 0.3 mg per kilogram of body weight (0.14 mg per pound) slowly intravenously. (2) Indications for use. For the control of abdominal pain (colic) associated with spasmodic colic, flatulent colic, and simple impactions. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.